Welcome to our dedicated page for REGAL REXNORD SEC filings (Ticker: RRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Regal Rexnord Corporation filings document the regulatory record of a Wisconsin industrial manufacturer with common stock listed on the New York Stock Exchange under RRX. Its 8-K reports disclose quarterly operating results, Regulation FD materials, executive succession and compensatory arrangements, shareholder meeting results and material financing agreements.
Proxy and annual meeting disclosures cover director elections, advisory compensation votes, auditor ratification, executive pay and board governance. Financing filings describe credit agreements, revolving and term-loan facilities, interest-rate mechanics and debt covenants, while results filings provide formal disclosures tied to the company’s motion-control, power transmission and power-efficiency businesses.
REGAL REXNORD CORP senior vice president Alexander P. Scarpelli reported a small equity award tied to dividends. He acquired 2.537 additional restricted stock units valued at $209.35 per share through a dividend equivalent reinvestment feature on existing awards, bringing his direct common stock holdings to 3,472.938 shares.
He also reports outstanding stock appreciation rights linked to 1,015 underlying shares at a $154.20 exercise price expiring on February 23, 2033, and 1,193 underlying shares at a $168.47 exercise price expiring on February 23, 2034. These rights vest 34% after one year, 67% after two years, and fully after three years from grant.
Regal Rexnord executive Cheryl Lewis, EVP and Chief HR Officer, reported receiving 8.681 additional restricted stock units of common stock at a reference price of $209.35 per share through a dividend equivalent reinvestment provision tied to prior awards.
Following this grant, her directly held common stock position increased to 14,908.665 shares. She also continues to hold several stock appreciation right awards on common stock with exercise prices between $133.77 and $168.47, which expire between 2031 and 2034 under their original vesting schedules.
REGAL REXNORD CORP director Michael P. Doss received additional stock-based compensation through dividend equivalents. On the reported date, he acquired 3.961 shares of common stock in the form of restricted stock units valued at $209.35 per share. These units were credited under a dividend equivalent reinvestment feature tied to his existing restricted stock unit awards and are subject to the same vesting terms. Following this grant, he holds 3,904.48 shares of common stock directly.
Regal Rexnord Corp executive Kevin Long received a small stock award, increasing his direct holdings. On April 14, 2026, he acquired 12.501 shares of common stock at $209.35 per share as a grant or award, bringing his direct ownership to 7,490.074 shares.
Regal Rexnord Corp director Rashida A. Hodge reported a small equity-based compensation adjustment. She acquired 2.165 shares of common stock at $209.35 per share through additional restricted stock units credited under a dividend equivalent reinvestment provision. Following this award, she directly holds 1,297.305 shares.
REGAL REXNORD CORP executive Hugo Dubovoy Jr., EVP, General Counsel & Secretary, was credited with 9.56 restricted stock units of common stock on the basis of a $209.35 per-share value. These additional units arose from a dividend equivalent reinvestment tied to his existing restricted stock unit awards and follow the same vesting terms.
After this credit, Dubovoy directly holds 8,861.751 shares of common stock. He also holds stock appreciation rights over 2,653 underlying common shares with a $176.01 exercise price, vesting in stages (34%, 67%, then 100%) and expiring in 2034.
Regal Rexnord EVP and Pres. IPS* Jerrald R. Morton reported a small equity award tied to dividends rather than market trading. He received 12.473 additional restricted stock units at a reference price of $209.35 per share through a dividend equivalent reinvestment feature on his existing awards.
After this credit, Morton directly holds 26,196.235 shares of common stock. He also holds stock appreciation rights over 5,304 underlying shares at an exercise price of $154.20 and 5,171 underlying shares at $168.47. These rights vest gradually over three years under a scheduled vesting schedule, reflecting ongoing incentive-based compensation rather than open-market buying or selling.
REGAL REXNORD CORP director Robin A. Walker-Lee received a small stock-based award tied to existing grants. On April 14, the director acquired 2.165 shares of common stock at $209.35 per share through additional restricted stock units credited under a dividend equivalent reinvestment feature. After this award, direct holdings reported in this account total 5,877.101 shares, and the new units follow the same vesting terms as the underlying restricted stock unit awards.
STOELTING CURTIS W reported acquisition or exercise transactions in this Form 4 filing.
REGAL REXNORD CORP director Curtis W. Stoelting received an additional 2.165 restricted stock units of Common Stock on a grant basis at $209.35 per share value, credited under the dividend equivalent reinvestment feature tied to his existing restricted stock unit awards.
After this credit, he holds 11,119.101 Common Stock shares directly, and 15,993 shares are held indirectly by the Stoelting Family Trust dated February 15, 2023, which is shown as trust ownership in the filing.
REGAL REXNORD CORP Chief Executive Officer Louis V. Pinkham received an automatic equity credit tied to existing awards. On April 14, 2026, he acquired 31.081 shares of Common Stock at a reference value of $209.35 per share through dividend-equivalent reinvestment on his outstanding restricted stock units, which continue to follow the same vesting terms. Following this credit, he directly holds 76,748.545 Common Stock shares. He also holds stock appreciation rights over 10,009 underlying Common Stock shares with a $154.20 exercise price expiring on February 23, 2033, and over 18,850 underlying Common Stock shares with a $168.47 exercise price expiring on February 23, 2034, which vest 34% after one year, 67% after two years, and 100% after three years from grant.